Kringle Pharma, Inc.

Kringle Pharma, Inc. is a biotechnology company based in Kita, Japan, that researches and develops therapeutic agents for intractable diseases. Its lead programs focus on HGF products for acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. The company was incorporated in 2001.